Efficacy and Safety of Modified Huang-Lian-Jie-Du Decoction Cream on Cancer Patients with Skin Side Effects Caused by EGFR Inhibition

Ming-Yang Lee,Mei-Yi Lin,Yu-Ju Chang,Yu-Ting Tseng,I-An Huang,Wan-Ting Huang,Yi-Wen Liu

DOI: https://doi.org/10.3390/pr9071081

IF: 3.5

2021-06-22

Processes

Abstract:(1) Background: The epidermal growth factor inhibitors (EGFRIs)/tyrosine kinase inhibitors (TKIs) are effective for cancer target therapy, but acneiform rashes or so-called inflammatory papulopustular exanthemas are common (50% to 90%). The conventional therapy for EGFRIs/TKIs-induced skin toxicity is steroids and antibacterial drugs, but it is still ineffective for some patients, and EGFRIs/TKIs dose reduction/interruption may be needed. In this study, a modified Chinese herbal medicine, Huang-Lian-Jie-Du decoction cream with Yin-Cold (YC) medicine characteristic, was investigated for the effect on patients suffering EGFRIs/TKIs-induced skin toxicity. (2) Methods: The modified Huang-Lian-Jie-Du (mHLJD) decoction cream was made from 10 herbal medicines, including 4 major medicines (Huanglian, Huangqin, Huangbo, and Zhizi) in traditional HLJD decoction. Patients with EGFRIs/TKIs-induced skin toxicity were enrolled. Patients were excluded if they also used other cream for skin toxicity. Skin conditions were monitored by follow up every 2 weeks. The patients’ characteristics, the skin toxicities, treatment response, and adverse events were recorded and analyzed until skin problems resolved or the study ended. (3) Results: The mHLJD decoction cream and its sub-packages were stored at 4 °C before use. Thirty-four patients who had grade 1–3 skin toxicities after receiving EGFRIs/TKIs were enrolled. Seven patients withdrew or were excluded. Finally, data from 27 patients were analyzed. The mean grade of rash acneiform was significantly decreased from 2.19 (ranged 1 to 3) to 0.88 (ranged 0 to 2) after mHLJD decoction cream treatment for 4 weeks and to 0.55 (ranged 0 to 2) after mHLJD decoction cream treatment for 8 weeks. Additionally, the mean grade of dry skin was also significantly decreased from 1.57 (ranged 1 to 2) to 0.71 (ranged 0 to 1) after mHLJD decoction cream treatment for 4 weeks. The changes of skin toxicity were significant, with no obvious adverse events. (4) Conclusions: In summary, the mHLJD decoction cream provides benefits for alleviation of EGFRIs/TKIs-induced skin rash acneiform and dry skin. Additionally, no obvious side effects were found in patients using mHLJD decoction cream.

engineering, chemical

What problem does this paper attempt to address?

The paper attempts to address the issue of skin side effects caused by EGFR inhibitors (EGFRIs)/tyrosine kinase inhibitors (TKIs) in cancer treatment, particularly acneiform rash and dry skin. Although these drugs are effective in cancer treatment, they lead to acneiform rash or so-called inflammatory papulopustular erythema in 50% to 90% of patients, severely affecting their quality of life, increasing the risk of infection, and reducing psychosocial activities. Traditional treatments such as antibiotics and steroids are ineffective for some patients and sometimes require dose reduction or interruption of EGFRIs/TKIs. Therefore, researchers tried a modified traditional Chinese medicine formula—Huanglian Jiedu Decoction ointment (mHLJD) to evaluate its effect on alleviating skin toxicity caused by EGFRIs/TKIs. The study validated the efficacy and safety of this ointment through clinical trials, particularly in reducing acneiform rash and dry skin.